Dr Suraj Kumar Ch - Medical Gastroenterologist in Hyderabad

ABSTRACTS AND PRESENTATIONS

• Poster presentation on “Overlap Syndromes in Pediatric population – Diagnostic and Therapeutic Challenges” at DRILLS in October 2024
• Case presentation “Hepatocellular Carcinoma presenting with Hepatic Venous Outflow Tract Obstruction in Cirrhosis of Liver due to Chronic Hepatitis C” at the Gastroenterology Young Masters held at Coimbatore in April 2024
• Platform presentation on “Primary sclerosing cholangitis presenting as decompensated chronic liver disease in pediatric Ulcerative colitis” at TS-ISG Gut Club held at Hyderabad in May 2024
• Poster presentation on “Duodenal Metastatic melanoma presenting with Melena” at ENDOCON held in New Delhi in May 2024
• Poster presentation on “Management of Anastomotic strictures post Tracheoesophageal fistula repair in pediatric population – A Tertiary Center Experience using CRE dilatation” at ISGCON held at Bangalore in January 2024
• Poster presentation “Mauriac syndrome – an uncommon cause of transaminemia in a 10-year-old child with Type 1 Diabetes Mellitus” at INASL held at Bhubaneswar in July 2023
• Poster presentation “Parkinson Plus syndrome – A tertiary centre experience” at APICON held at Agra in January 2020
• Platform presentation on “Posterior reversible encephalopathy syndrome secondary to blood transfusion” at TS-APICON held at Karimnagar in August 2019

ORGANIZATIONAL AND ADMINISTRATIVE POSITIONS

• Part of the organizing team for GYM – ISG South Zone (Gastroenterology Young Masters) 2023

 PUBLICATIONS

• Case report on “Abdominal wall hematoma post diagnostic paracentesis” in the Indian Society of Gastroenterology journal as an abstract presentation, 2022
• Case report on “Acanthosis nigricans-A rare cutaneous association in progressive familial intrahepatic cholestasis” in the Indian Society of Gastroenterology journal as an abstract presentation, 2022
• Case report on “Irritable bowel syndrome complicating asymptomatic nonrotation of midgut” in the Indian Society of Gastroenterology journal as an abstract presentation, 2022
• Case series on “Duodenal Neuroendocrine tumors – A Tertiary centre experience and review of literature” in World Journal of Translational Medicine, 2023
• Case report on “Spontaneous cervical esophagus perforation” in the Indian Journal of Applied Research, 2023
• Case report on “A rare case of non-HFE haemochromatosis” in the Journal of Clinical and Experimental Hepatology, 2023
• Case series on “Challenges in differentiating Gastrointestinal Tuberculosis and Crohn’s disease in a tertiary care hospital” in the International Journal of Scientific Research, 2024
• Case series on “Button Battery Ingestion in Children - A Tertiary Center Experience in Endoscopic Management and a Brief Review of the Literature” in the International Journal of Science and Research, 2024
• Case report on “Mitochondrial Neurogastrointestinal Encephalomyopathy Syndrome Caused by a Novel Mutation and Review of Therapeutic Modalities” in the Osmania Journal of Medical Research, 2025

PUBLICATIONS IN COMMUNICATION

• Duodenal web presenting with bilious vomiting and amenorrhea in a 14-year-old female child – Endoscopic Balloon dilatation
• Controversial cause of chronic diarrhea –Intestinal Spirochetosis  Case report and review of literature
• Uncommon ERCP complication - Portobiliary fistula – Case report and review of management modalities
• Overlap syndromes in the pediatric population – case series
• Brush cytology of biliary strictures – Tertiary care centre experience
• Autoimmune liver diseases – Case series on AIH, PBC, PSC and overlap syndromes at Tertiary Care Center

RESEARCH ACTIVITIES

• Sub-Investigator in “UCESIVE – Efficacy, Safety and Immunogenicity of Vedolizumab biosimilar PB016 - Phase 3 randomized, double blind, multicentre clinical trial involving patients with moderately to severely active Ulcerative Colitis”
• Sub-Investigator in “A phase 4, non-randomized, multicentre, open-label, single-arm study to evaluate the safety and efficacy of Saroglitazar 4mg in patients with Non-Alcoholic Fatty Liver Disease (NAFLD) with comorbidities (either obesity, type 2 diabetes mellitus, dyslipidemia, or metabolic syndrome)”
• Sub-Investigator in “A randomized, multicentre, two-arm, active-controlled, parallel, double blind, comparative study to evaluate the efficacy and safety of Esomeprazole dual release gastro-resistant tablets in comparison to Esomeprazole tablets in patients with Refractory GERD”
• Sub-Investigator in “A randomized, multicentre, double blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of Linaclotide in patients with chronic idiopathic constipation”